Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2024-11-19

DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ rallied 6.97% to $7.83 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.60% to 18,791.81 and the Dow Jones Industrial Average falling 0.13% to 43,389.60.

This was the stock's second consecutive day of gains.

Novavax Inc. closed $16.03 short of its 52-week high ($23.86), which the company reached on June 6th.

The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.50% to $154.77, Pfizer Inc. $(PFE)$ rose 0.24% to $24.86, and Merck & Co. Inc. $(MRK)$ rose 0.26% to $96.56.

Trading volume (6.9 M) eclipsed its 50-day average volume of 6.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 18, 2024 17:29 ET (22:29 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10